4.7 Letter

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first- line treatment of metastatic colorectal cancer: Updated results from the BICC-C study

Related references

Note: Only part of the references are listed.
Meeting Abstract Oncology

A phase I trial of RX-0201 (AKT anti-sense) in patients with an advanced cancer

J. Marshall et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)